Strengths and limitations
Strengths of our study include the use of a commercially available population health management tool, clinically prescribed CGM technology, and implementation of RPM with limited provider resources (one clinician), all of which replicate real world circumstances for many endocrinology practices. Our study population included adolescent and pre-adolescent aged participants, and a large proportion (>40%) with public insurance, which increases the generalizability of our findings. However, generalizability is limited by the fact that our cohort was majority non-Hispanic White, had unanimous CGM use and a high rate of insulin pump use, and demonstrated relatively good glycemic control at baseline.Our small sample size was not powered to detect significant changes in glycemic control, as this study was designed primarily to explore feasibility, satisfaction, and efficiency measures. However, the fact that we did evaluate glycemic change 